Arax Advisory Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
14,292
+13,912
+3,661% +$2.32M 0.01% 817
2026
Q1
$79.7K Sell
380
-40
-10% -$10.1K ﹤0.01% 1493
2025
Q4
$119K Sell
420
-1,261
-75% -$394K ﹤0.01% 1258
2025
Q3
$519K Buy
1,681
+1,522
+957% +$477K 0.01% 885
2025
Q2
$50K Buy
159
+30
+23% +$8.66K ﹤0.01% 1234
2025
Q1
$33.9K Sell
129
-57
-31% -$15.4K ﹤0.01% 1099
2024
Q4
$48.6K Buy
186
+56
+43% +$14.1K ﹤0.01% 916
2024
Q3
$30.3K Buy
130
+38
+41% +$7.8K ﹤0.01% 919
2024
Q2
$18.6K Buy
92
+62
+207% +$11.2K ﹤0.01% 993
2024
Q1
$5.14K Hold
30
﹤0.01% 895
2023
Q4
$6.51K Buy
30
+28
+1,400% +$4.8K ﹤0.01% 835
2023
Q3
$319 Sell
2
-4
-67% -$896 ﹤0.01% 1264
2023
Q2
$1.73K Sell
6
-1
-14% -$304 ﹤0.01% 1027
2023
Q1
$2.23K Hold
7
﹤0.01% 985
2022
Q4
$2.06K Buy
7
+4
+133% +$1.1K ﹤0.01% 935
2022
Q3
$1K Buy
+3
New +$751 ﹤0.01% 1132

Other funds holding PODD

Arax Advisory Partners's PODD Position: Q2 2026 in Review

Arax Advisory Partners increased its Insulet (PODD) stake by 3,661% in Q2 2026, buying an estimated $2.32M and bringing the position to 14,292 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #817.

Arax Advisory Partners first reported a position in PODD in Q3 2022 and has held it in 16 quarters since. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Arax Advisory Partners held 14,292 shares of Insulet worth $2.18M as of Q2 2026.
  • Arax Advisory Partners bought 13,912 Insulet shares in Q2 2026, an estimated $2.32M.
  • Insulet made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #817 holding.
  • Arax Advisory Partners first reported a position in Insulet in Q3 2022 and has held it in 16 quarters since.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.